SCHEMBL6591706

SCHEMBL6591706

COc1cc2c(Cl)c(N)cnc2cc1OCCCC1CCCNC1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 9/20 0.44
▸ KIT P10721 1/20 0.41
▸ ACP1 P24666 7/20 0.41
▸ ABL1 P00519 1/20 0.40
▸ SRC P12931 1/20 0.40
▸ ABL2 P42684 1/20 0.40
▸ EHMT1 Q9H9B1 1/20 0.40
▸ AXL P30530 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ MERTK Q12866 1/20 0.40
▸ EPHA2 P29317 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ EPHB4 P54760 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6336434 0.89 EHMT2 (0.44) EHMT2KITACP1ABL1SRC
SCHEMBL6338533 0.86 SRC (0.51) EHMT2KITABL1SRCABL2
SCHEMBL6336695 0.85 ACP1 (0.41) EHMT2KITACP1ABL1SRC
SCHEMBL6337390 0.82 KDM4E (0.46) EHMT2KITACP1
SCHEMBL6344436 0.79 SRC (0.47) EHMT2KITABL1SRCABL2
SCHEMBL6343097 0.79 ACP1 (0.42) EHMT2KITACP1AXLFLT3
SCHEMBL14155221 0.78 ENPP1 (0.48) EHMT2SRCEHMT1
SCHEMBL6986140 0.77 KDR (0.48) EHMT2KITAXLFLT3MERTK
SCHEMBL4593476 0.77 ENPP1 (0.59) EHMT2KITAXLFLT3MERTK
SCHEMBL4590452 0.77 ENPP1 (0.59) EHMT2KITAXLFLT3MERTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490362-A2 (HOMO)PIPERAZINE SUBSTITUTED QUINOLINES FOR INHIBITING THE PHOSPHORYLATION OF KINASES Millennium Pharmaceuticals, Inc. (US) 2004-12-29 — — EP disclosed
WO-2002072578-A2 (HOMO) PIPERAZINE SUBSTITUTED QUINOLINES FOR INHIBITING THE PHOSPHORYLATION OF KINASES MILLENNIUM PHARMACEUTICALS (US) 2002-09-19 — — WO disclosed
Send feedback